AzTrials
AzTrials

Acute Pain ManagementNCT06839742

Does Adding Posterior Block to SFIB Increase the Quality of Analgesia in Hip Fractures?

A study testing Deep Posterior Gluteal Compartment Block and Suprainguinal fascia iliaca compartment block in people with Acute Pain Management and Hip Surgery, run by Samsun University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The researchers aimed to compare the effects of adding a Deep Posterior Gluteal Compartment Block to a Suprainguinal Fascia Iliaca Compartment Block (SFICB) versus SFICB alone on pain, analgesic consumption, and positioning pain for neuraxial anesthesia. Read more about this study

Who is it for?
Ages 18 to 90 years
Conditions the study is for
Acute Pain Management, Hip Surgery
What is being tested?
Deep Posterior Gluteal Compartment Block and Suprainguinal fascia iliaca compartment block
Could I receive a placebo?
No, everyone receives an active treatment
How many people
68 participants
Where
1 siteTurkey (Türkiye)
Study dates
24 Feb 2025to 31 Dec 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 90 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Volunteering to participate in the study
  • Patients between the ages of 18-90
  • ASA I, II, III
  • Patients whose surgery duration does not exceed 2 hours
  • Patients who will undergo surgery under spinal anesthesia

Who cannot join

  • Patients who do not want to participate in the study/do not give consent
  • Patients with a condition that prevents regional anesthesia
  • Patients with cognitive dysfunction who are unable to evaluate the NRS score and who cannot use PCA (Patient Controlled Analgesia Device)
  • History of hypersensitivity or allergy to local anesthetics
  • Patients with psychiatric disorders and those using psychiatric medications
  • Presence of hematological disease
Show all 13Show fewer
  • Presence of oncological disease
  • Patients with serious major organ failure
  • Presence of multiple fractures
  • Patients with alcohol or drug addiction
  • Patients who have used analgesic drugs up to 12 hours before surgery
  • ASA IV-V patients
  • Morbidly obese patients

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Samsun University, Samsun Training and Research Hospital

    Samsun, Ilkadım

Other trials in Turkey (Türkiye)

About this study

Official title: Does the Addition of a Deep Posterior Gluteal Compartment Block to Suprainguinal Fascia Iliaca Block Improve Analgesia in Hip Fracture Surgery? A Randomized Controlled Trial

The researchers aimed to compare the effects of adding a Deep Posterior Gluteal Compartment Block to a Suprainguinal Fascia Iliaca Compartment Block (SFICB) versus SFICB alone on pain, analgesic consumption, and positioning pain for neuraxial anesthesia.

Read the detailed description

Adding Deep Posterior Gluteal Compartment Block to Suprainguinal Fascia Iliaca Block applied before neuraxial anesthesia in hip fracture surgeries can reduce the pain sensation originating from the posterior region of the hip joint. Thus, participants can experience less pain in the perioperative period, consume less analgesics and reduce complications related to these in the postoperative period. In addition, possible complications can be prevented with early mobilization of the participants. It was aimed to compare the effects of adding Deep Posterior Gluteal Compartment Block to Suprainguinal Fascia Iliaca Block with only Suprainguinal Fascia Iliaca Block on these results.

Being tested
Deep Posterior Gluteal Compartment Block, Suprainguinal fascia iliaca compartment block
Keywords
acute pain management, hip surgery, Deep posterior gluteal compartment block, Suprainguinal fascia iliaca plane block

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Deep Posterior Gluteal Compartment BlockOther

    Deep Posterior Gluteal Compartment Block will be performed under USG guidance before neuraxial anesthesia.

  • Suprainguinal fascia iliaca compartment blockOther

    Suprainguinal fascia iliaca compartment block will be performed under USG guidance before neuraxial anesthesia.

Study groups in NCT06839742
Study groupRoleWhat they receive
Group SFICBActive comparatorSuprainguinal fascia iliaca plane block will be performed 30 minutes before hip surgery
Receives: Other: Suprainguinal fascia iliaca compartment block
Group CombinedActive comparatorSuprainguinal Fascia İliaca plane Block will be performed 30 minutes before hip surgery and Deep Posterior Gluteal Compartment Block will be performed 20 minutes before hip surgery
Receives: Other: Deep Posterior Gluteal Compartment Block; Other: Suprainguinal fascia iliaca compartment block

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Opioid consumption

    In the postoperative period, patients will be given opioids according to their pain density with a patient-controlled device, and the daily Morphine consumption in Patient Controlled Analgesia device will be collected and compared between groups.

    Measured: 24 hours

Secondary outcomes (4)
  1. Perioperative pain intensity

    Changes in the Numerical Rating Scale (NRS) will be recorded at rest and during movement. The participant's baseline NRS will be recorded, followed by measurements before and after neuraxial positioning and up to 24 hours post-surgery.

    The NRS is a unidimensional measure of pain intensity in adults. It is a segmented numerical version of the Visual Analog Scale (VAS) where the participant selects a whole number (0-10) that best represents the intensity of their pain. The 11-point numerical scale ranges from '0' representing one end of the pain spectrum (e.g. 'no pain') to '10' representing the other end (e.g. 'worst imaginable pain').

    Measured: 24 hours

  2. Quality of recovery 15 scale

    Postoperative Quality of Recovery 15 in Turkish scale

    Measured: 24 hours after surgery

  3. Quality of patient's position for neuraxial anesthesia

    The position will be evaluated by anesthesiologist and characterized as "unsatisfactory", "satisfactory", "good" or "very good"

    Measured: up to ten minutes

  4. Quadriceps weakness

    Quadriceps strength will be graded according to a 3-point scale: normal strength = 0 point (extension against resistance); paresis = 1 point (extension against gravity but not against resistance); and paralysis = 2 points (no extension).

    Measured: 24th hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Feb 2025
  2. Study start24 Feb 2025
  3. Primary completion15 Dec 2025
  4. Study completion31 Dec 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Care provider, Outcomes assessor
Enrolment
68 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06839742
Sponsor's protocol ID
OMUKAEAK 2024/276
Status last verified
Feb 2025
First submitted
11 Dec 2024
Last updated
6 Jan 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.

Publications

  • Safa B, Trinh H, Lansdown A, McHardy PG, Gollish J, Kiss A, Kaustov L, Choi S. Ultrasound-guided suprainguinal fascia iliaca compartment block and early postoperative analgesia after total hip arthroplasty: a randomised controlled trial. Br J Anaesth. 2024 Jul;133(1):146-151. doi: 10.1016/j.bja.2024.04.019. Epub 2024 May 18.

    PubMed 38762396
  • Roche JJ, Wenn RT, Sahota O, Moran CG. Effect of comorbidities and postoperative complications on mortality after hip fracture in elderly people: prospective observational cohort study. BMJ. 2005 Dec 10;331(7529):1374. doi: 10.1136/bmj.38643.663843.55. Epub 2005 Nov 18.

    PubMed 16299013
  • Vermeylen K, Van Aken D, Versyck B, Casaer S, Bleys R, Bracke P, Groen G. Deep posterior gluteal compartment block for regional anaesthesia of the posterior hip: a proof-of-concept pilot study. BJA Open. 2023 Feb 15;5:100127. doi: 10.1016/j.bjao.2023.100127. eCollection 2023 Mar.

    PubMed 37587997

Questions about this trial

What is this clinical trial studying?

A study testing Deep Posterior Gluteal Compartment Block and Suprainguinal fascia iliaca compartment block in people with Acute Pain Management and Hip Surgery, run by Samsun University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Opioid consumption (time frame: 24 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06839742, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Jan 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in